Skip to content

Effects of Repetitive Transcranial Magnetic Stimulation (rEMT) in Obesity

Effects of Repetitive Transcranial Magnetic Stimulation (rEMT) on subjective signs of hunger and satiety in Obesity: a randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9x9kctn
Enrollment
Unknown
Registered
2023-12-07
Start date
2022-11-17
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

The volunteers are submitted to 24 sessions of repetitive transcranial magnetic electrostimulation (rEMT), 10 Hz, about 20 minutes, active or sham, on the left dorsolateral prefrontal cortex, for 8 we
E02.621.820

Sponsors

Instituto de Neuromodulação e Reabilitação Avançada (INERVA)
Lead Sponsor
Instituto de Neuromodulação e Reabilitação Avançada (INERVA)
Collaborator

Eligibility

Age
18 Years to 59 Years

Inclusion criteria

Inclusion criteria: Adult volunteers; 18 to 59 years of age; of both sexes; diagnosed with obesity to any degree for body mass index (BMI)

Exclusion criteria

Exclusion criteria: Eutrophic, overweight and malnourished volunteers for BMI; who have contraindications to rEMT or have received rEMT in the last 12 months; who present any head injury, previously documented epilepsy, presence of psychiatric disorder (schizophrenia and bipolar disorder); who have metal implants in their heads; who use or have used anti-obesity drugs (sibutramine, topiramate, orlistat and liraglutide) in the last 3 months; who are addicted to illicit drugs in the last 5 years; who have Cushing's Syndrome; who are pregnant or breastfeeding

Design outcomes

Primary

MeasureTime frame
It is expected to find a reduction in subjective levels of hunger and increased satiety in obese patients, verified by the Visual Analogue Scale (VAS), from a reduction in measurements of 60% comparing sham group and treatment

Secondary

MeasureTime frame
A reduction of 5% in anthropometric measurements is expected, as verified by physical evaluation, comparing sham group and treatment;A reduction in the level of binge eating is expected to be 5%, verified by the Binge Eating Scale, comparing the sham group and treatment;Modifications in laboratory tests of 5% are expected, verified by biochemical tests, comparing sham group and treatment

Countries

Brazil

Contacts

Public ContactJoelso Peralta

Instituto de Neuromodulação e Reabilitação Avançada (INERVA)

peraltanutri@gmail.com+55 (51) 9480-1592

Outcome results

None listed

Source: REBEC (via WHO ICTRP)